Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Transfusion ; 51 Suppl 1: 50S-57S, 2011 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-21223296

RESUMO

BACKGROUND: There is increasing international interest in producing components from blood that has been stored at room temperature for 24 hours. The lack of comprehensive data on the quality of plasma produced from blood stored in this way led to this international study. STUDY DESIGN AND METHODS: A total of 128 units of whole blood were pooled in groups of four and split to produce 32 sets of four identical blood units that were processed either within 8 hours of blood collection or after 24-hour storage at 18 to 25°C. RESULTS: Storage of whole blood for 24 hours resulted in a 23% decrease in the activity of Factor (F)VIII, but not significant loss of activity of coagulation factors FV, FVII, FXI, FXII, fibrinogen, antithrombin, or von Willebrand factor. There was a small, but significant decrease in levels of FII, FIX, and FX (all <5%) as well as protein C (6%) and free protein S activity (14%). The ability of plasma to generate thrombin after 24-hour storage as whole blood was unaltered, as assessed by real-time thrombin generation tests as was the rate and strength of clot formation by rotational thombelastometry. Levels of all coagulation factors measured were above 0.50 U/mL in plasma produced from whole blood stored for 24 hours. CONCLUSION: These data show that there is minimal effect of storing whole blood at ambient temperature for 24 hours on the coagulation activity of plasma and that this is an acceptable alternative to producing plasma on the day of blood collection.


Assuntos
Fatores de Coagulação Sanguínea/análise , Remoção de Componentes Sanguíneos/métodos , Preservação de Sangue/métodos , Sistema ABO de Grupos Sanguíneos/análise , Fatores de Coagulação Sanguínea/isolamento & purificação , Sistemas Computacionais , Fator VIII/análise , Feminino , Hemostasia , Humanos , Procedimentos de Redução de Leucócitos , Masculino , Tempo de Tromboplastina Parcial , Plasma , Estabilidade Proteica , Tempo de Protrombina , Temperatura , Tromboelastografia , Trombina/biossíntese , Fatores de Tempo
2.
Zentralbl Chir ; 127(9): 752-4, 2002 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-12221554

RESUMO

Antithrombotic regimens to prevent venous thromboembolism are standard in the treatment of in-and outpatients with thrombotic risk factors. A classification of the level of risk is made depending on the age, kind of operation, existing hereditary or acquired thrombophilic diatheses and concomitant disease. The antithrombotic prophylaxis is performed in accordance with the classification of risk level in low, moderate, high and highest risk levels. Varicose disease is a thrombotic risk factor. Varicose vein surgery may be classified as thrombogenic. Patients with varicose vein surgery and without other clinical risk factors are low-risk patients. In case of other acquired or hereditary risk factors antithrombotic prophylaxis in varicose vein surgery with low molecular weight heparin should be used. Compression elastic stockings are obligatory.


Assuntos
Fibrinolíticos/administração & dosagem , Complicações Pós-Operatórias/prevenção & controle , Embolia Pulmonar/prevenção & controle , Varizes/cirurgia , Trombose Venosa/prevenção & controle , Heparina de Baixo Peso Molecular/administração & dosagem , Humanos , Complicações Pós-Operatórias/etiologia , Embolia Pulmonar/etiologia , Fatores de Risco , Resultado do Tratamento , Trombose Venosa/etiologia
3.
Thorac Cardiovasc Surg ; 50(1): 25-30, 2002 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11847600

RESUMO

BACKGROUND: Continuous antegrade blood cardioplegia (CABCP) is used at different temperatures. We investigated the consequences of CABCP at 6 degrees C (COLD) vs. 28 degrees C (TEPID). METHODS: Anesthetized open-chest pigs (25 +/- 2 kg) were placed on cardiopulmonary bypass (CPB). The hearts were arrested for 30 min by 6 degrees C cold or 28 degrees C tepid CABCP (n = 8 each). After an initial 3 min antegrade application of high potassium (20 mEq) cold (6 degrees C) blood cardioplegia, the hearts were arrested for a subsequent 27 min by normokalemic blood delivered antegrade at either 6 degrees C or 28 degrees C. After this, the hearts underwent perfusion with warm systemic blood for an additional 30 min on CPB. Biochemical cardiac data (MVO2 [ml/min/100 g], release of creatine kinase [CK U/min/100 g] and lactate [mg/min/100 g]) were measured during CPB. Total tissue water content (%) and left ventricular stroke work index (SWI g x m/kg) were determined 30 min after discontinuation of CPB and compared to pre-CPB controls. RESULTS: Cold CABCP kept all hearts continuously arrested. The COLD hearts showed no biochemical or functional disturbance. The TEPID hearts intermittently fibrillated and required additional high potassium BCP shots. The TEPID hearts showed a marked CK leakage (2.6 +/- 0.4 vs. 0.7 +/- 0.4), lactate production (4.0 +/- 1.6 vs. extraction from the COLD group) despite the non-ischemic protocol, an impaired initial oxygen consumption (4.2 +/- 1.3 vs. 7.1 +/- 1.6) at the end of cardiac arrest, the formation of myocardial edema (79.5 +/- 1.0 vs. 77.0 +/- 0.8), and a depressed recovery of SWI (0.69 +/- 0.15 degrees vs. 1.41 +/- 0.13). *p < 0.05 for comparison of TEPID vs. COLD hearts using Student's t-test for unpaired data; degrees p < 0.05 for intergroup-comparison of TEPID vs. COLD vs. controls using ANOVA adjusted for repeated measures. CONCLUSIONS: Uninterrupted cardioplegia can be safely performed with cold normokalemic CABCP. In contrast, tepid normokalemic CABCP leads to fibrillation, jeopardizes the heart, and should be avoided.UND


Assuntos
Soluções Cardioplégicas/uso terapêutico , Parada Cardíaca Induzida/métodos , Animais , Ponte Cardiopulmonar , Temperatura Baixa , Creatina Quinase/sangue , Ácido Láctico/sangue , Modelos Animais , Consumo de Oxigênio , Volume Sistólico , Suínos
4.
Thorac Cardiovasc Surg ; 49(4): 254-5, 2001 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-11505329

RESUMO

BACKGROUND: Risk scores (RS) in heart surgery assess mortality and morbidity and mirror the degree of severity of disease of the patients when presented for surgery. We examined the use and dissemination of RS in Germany. MATERIAL AND METHODS: Our survey included 79 German heart surgery institutes in Fall 1999 and Winter 2000. RESULTS: Four institutes did not respond. Out of 75 (ad 100 %) responders 56 (75 %) institutes did not use RS, 17 (22 %) institutes used one RS method and 2 (3 %) institutes used two RS methods. The most frequently applied RS methods were the Cleveland Clinic Score and the Euro Score (n = 7, each) followed by institution-specific, internally developed RS methods (n = 5), Parsonnet's RS (n = 1) and the RS from the STS database (n = 1). Fourteen institutes used RS for internal quality control. Of these, 2 institutes publish their RS data for external quality control. The patient-related individual procedure risk was used in 6 institutes. CONCLUSIONS: A quarter of the German heart surgery institutes use one or more RS methods. The most commonly used were the Cleveland Clinic Score and the Euro Score, followed by internally developed RS methods. RS methods were most frequently used for internal quality control. The degree of the severity of disease of the patients who presented for surgery could only be compared between a small number of institutes using the same RS.


Assuntos
Cardiopatias/cirurgia , Complicações Pós-Operatórias/mortalidade , Medição de Risco , Causas de Morte , Comparação Transcultural , Europa (Continente) , Cardiopatias/mortalidade , Humanos , Garantia da Qualidade dos Cuidados de Saúde , Estados Unidos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...